MA
ABBV icon

MBA Advisors’s AbbVie ABBV Stock Holding History

MBA Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
5,970
+163
+3% +$35.1K 0.51% 43
2026
Q1 		$1.26M Buy
5,807
+679
+13% +$151K 0.49% 45
2025
Q4 		$1.17M Sell
5,128
-92
-2% -$21K 0.47% 47
2025
Q3 		$1.21M Sell
5,220
-405
-7% -$82.5K 0.52% 42
2025
Q2 		$1.04M Sell
5,625
-215
-4% -$40K 0.48% 49
2025
Q1 		$1.22M Buy
5,840
+96
+2% +$18.7K 0.61% 37
2024
Q4 		$1.02M Sell
5,744
-486
-8% -$89.4K 0.51% 47
2024
Q3 		$1.23M Buy
6,230
+12
+0.2% +$2.24K 0.59% 43
2024
Q2 		$1.07M Buy
6,218
+495
+9% +$82K 0.55% 45
2024
Q1 		$1.04M Sell
5,723
-423
-7% -$72.9K 0.54% 48
2023
Q4 		$952K Sell
6,146
-135
-2% -$19.7K 0.53% 47
2023
Q3 		$936K Buy
6,281
+19
+0.3% +$2.79K 0.57% 45
2023
Q2 		$844K Buy
6,262
+41
+0.7% +$6.01K 0.5% 48
2023
Q1 		$991K Buy
6,221
+169
+3% +$25.8K 0.62% 47
2022
Q4 		$978K Buy
6,052
+198
+3% +$30.4K 0.64% 43
2022
Q3 		$786K Buy
5,854
+604
+12% +$86.7K 0.57% 47
2022
Q2 		$804K Sell
5,250
-83
-2% -$12.7K 0.55% 51
2022
Q1 		$864K Sell
5,333
-786
-13% -$114K 0.54% 54
2021
Q4 		$828K Buy
6,119
+651
+12% +$76.9K 0.51% 54
2021
Q3 		$590K Buy
5,468
+61
+1% +$6.97K 0.44% 64
2021
Q2 		$609K Sell
5,407
-366
-6% -$41.2K 0.28% 62
2021
Q1 		$625K Buy
+5,773
New +$617K 0.34% 59

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MBA Advisors's ABBV Position: Q2 2026 in Review

MBA Advisors increased its AbbVie (ABBV) stake by 2.8% in Q2 2026, buying an estimated $35.1K and bringing the position to 5,970 shares worth $1.5M. The position accounts for 0.51% of the portfolio, ranked #43.

MBA Advisors first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • MBA Advisors held 5,970 shares of AbbVie worth $1.5M as of Q2 2026.
  • MBA Advisors bought 163 AbbVie shares in Q2 2026, an estimated $35.1K.
  • AbbVie made up 0.51% of MBA Advisors's portfolio in Q2 2026, its #43 holding.
  • MBA Advisors first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MBA Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.